3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Squamous Cell Carcinoma of Head and Neck
16
Oropharyngeal Neoplasms
10
Nasopharyngeal Carcinoma
10
Prostatic Neoplasms
7
Laryngeal Neoplasms
6
Rectal Neoplasms
5
Mouth Neoplasms
5
Hypopharyngeal Neoplasms
5
Head and Neck Neoplasms
5
Carcinoma
5
Carcinoma, Non-Small-Cell Lung
4
Esophageal Neoplasms
3
Carcinoma, Squamous Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Salivary Gland Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Nasopharyngeal Neoplasms
2
Mesothelioma
2
Epstein-Barr Virus Infections
2
Carcinoma, Intraductal, Noninfiltrating
2
Astrocytoma
2
Anus Neoplasms
2
Vaginal Neoplasms
1
Urothelial Carcinoma of the Bladder
1
Tongue Neoplasms
1
Thyroid Carcinoma, Anaplastic
1
Stomatitis
1
Stomach Neoplasms
1
Interventions
Doxorubicin
3
pembrolizumab
2
pazopanib
2
Radiotherapy
2
Radiation
2
Ifosfamide
2
selinexor
1
peposertib
1
liposomal doxorubicin
1
Specimen Handling
1
Proton Therapy
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
Imatinib Mesylate
1
Histamine H2 Antagonists
1
Famotidine
1
Dactinomycin
1
Cyclophosphamide
1
Blood Specimen Collection
1
Biopsy
1
BO-112
1
Angptl4 protein, mouse
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Dermatofibrosarcoma
×
Radiotherapy, Intensity-Modulated
×
90 days
×
Clear all
No trials found.